id	sid	eid	entity	type
eyereports-54	2	1	42	CARDINAL
eyereports-54	3	1	2011	DATE
eyereports-54	3	2	1	CARDINAL
eyereports-54	3	3	anja m. palmowski-wolfe,1 eva pape,2	PERSON
eyereports-54	6	1	2university basel	ORG
eyereports-54	6	2	3neurozentrum bern	PERCENT
eyereports-54	6	3	bern	ORG
eyereports-54	6	4	switzerland	GPE
eyereports-54	8	1	60-year-old	DATE
eyereports-54	8	2	iih	ORG
eyereports-54	9	1	swiss	NORP
eyereports-54	12	1	approximately a decade-and-a-half ago	DATE
eyereports-54	13	1	the bcr-abl	ORG
eyereports-54	14	1	fda	ORG
eyereports-54	14	2	cd117	ORG
eyereports-54	15	1	60-year-old	DATE
eyereports-54	15	2	caucasian	NORP
eyereports-54	16	1	more than 35 years	DATE
eyereports-54	17	1	the last 3 years	DATE
eyereports-54	17	2	novartis	ORG
eyereports-54	17	3	glivec	PERSON
eyereports-54	17	4	imatinib ut imatinib mesilate	ORG
eyereports-54	17	5	europe	LOC
eyereports-54	17	6	gleevec	PERSON
eyereports-54	17	7	us	GPE
eyereports-54	18	1	more than 30 kg	QUANTITY
eyereports-54	19	1	0.7	CARDINAL
eyereports-54	20	1	1	CARDINAL
eyereports-54	21	1	2	CARDINAL
eyereports-54	22	1	3	CARDINAL
eyereports-54	23	1	4 years	DATE
eyereports-54	23	2	4	CARDINAL
eyereports-54	24	1	5	CARDINAL
eyereports-54	25	1	38.5	CARDINAL
eyereports-54	26	1	349 mg	QUANTITY
eyereports-54	27	1	250	CARDINAL
eyereports-54	27	2	four	CARDINAL
eyereports-54	29	1	icp	ORG
eyereports-54	31	1	tasigna	PERSON
eyereports-54	31	2	novartis	ORG
eyereports-54	31	3	second	ORDINAL
eyereports-54	32	1	0.8	CARDINAL
eyereports-54	32	2	1.0	CARDINAL
eyereports-54	33	1	one	CARDINAL
eyereports-54	36	1	3 kg	QUANTITY
eyereports-54	36	2	2 months	DATE
eyereports-54	37	1	iih	PERSON
eyereports-54	38	1	half	CARDINAL
eyereports-54	39	1	iih	ORG
eyereports-54	39	2	cml	PRODUCT
eyereports-54	39	3	2011	DATE
eyereports-54	39	4	1	CARDINAL
eyereports-54	40	1	anja palmowski-wolfe	PERSON
eyereports-54	40	2	universität basel	ORG
eyereports-54	40	3	91	CARDINAL
eyereports-54	40	4	4031	CARDINAL
eyereports-54	40	5	basel	GPE
eyereports-54	40	6	switzerland	GPE
eyereports-54	43	1	30 may 2011	DATE
eyereports-54	44	1	30 september 2011	DATE
eyereports-54	45	1	30 october 2011	DATE
eyereports-54	46	1	3.0	CARDINAL
eyereports-54	46	2	3.0	CARDINAL
eyereports-54	47	1	palmowski-wolfe et al	PERSON
eyereports-54	47	2	2011	DATE
eyereports-54	47	3	italy	GPE
eyereports-54	47	4	2011	DATE
eyereports-54	47	5	1	CARDINAL
eyereports-54	47	6	doi:10.4081	PERSON
eyereports-54	47	7	1	CARDINAL
eyereports-54	49	1	mmerc	PERSON
eyereports-54	49	2	ial	ORG
eyereports-54	51	1	2011	DATE
eyereports-54	51	2	1	CARDINAL
eyereports-54	52	1	43	CARDINAL
eyereports-54	53	1	cml	PRODUCT
eyereports-54	55	1	iih	ORG
eyereports-54	56	1	iih	ORG
eyereports-54	57	1	iih	ORG
eyereports-54	58	1	one	CARDINAL
eyereports-54	58	2	10 months	DATE
eyereports-54	58	3	iih	ORG
eyereports-54	58	4	iih	ORG
eyereports-54	59	1	2	CARDINAL
eyereports-54	61	1	demarcates	GPE
eyereports-54	62	1	nfl	ORG
eyereports-54	63	1	3	CARDINAL
eyereports-54	64	1	2	CARDINAL
eyereports-54	66	1	4	CARDINAL
eyereports-54	67	1	asterisk	ORG
eyereports-54	68	1	5	CARDINAL
eyereports-54	69	1	asterisk	ORG
eyereports-54	71	1	non -co mmerc	ORG
eyereports-54	71	2	ial	ORG
eyereports-54	71	3	44	CARDINAL
eyereports-54	72	1	2011	DATE
eyereports-54	72	2	1	CARDINAL
eyereports-54	73	1	2002	DATE
eyereports-54	73	2	2	CARDINAL
eyereports-54	73	3	one	CARDINAL
eyereports-54	73	4	6 months	DATE
eyereports-54	74	1	30 kg	QUANTITY
eyereports-54	75	1	iih	ORG
eyereports-54	77	1	nilotinib	ORG
eyereports-54	77	2	second	ORDINAL
eyereports-54	77	3	iih	ORG
eyereports-54	78	1	iih	ORG
eyereports-54	78	2	swiss	NORP
eyereports-54	79	1	the swiss medical compendium	ORG
eyereports-54	80	1	1	CARDINAL
eyereports-54	80	2	mughal ti	PERSON
eyereports-54	80	3	schrieber a. principal long	PERSON
eyereports-54	81	1	2010;4:315-23	DATE
eyereports-54	82	1	2	CARDINAL
eyereports-54	82	2	mastocytosis leuk	PERSON
eyereports-54	82	3	2001;35	CARDINAL
eyereports-54	82	4	1143-52	CARDINAL
eyereports-54	83	1	3	CARDINAL
eyereports-54	83	2	kapoor kg	PERSON
eyereports-54	86	1	j neurosci 2010;120:471	PERSON
eyereports-54	86	2	4	CARDINAL
eyereports-54	86	3	abbot l	PERSON
eyereports-54	86	4	mioneau g	PERSON
eyereports-54	86	5	johnston d.	PERSON
eyereports-54	87	1	2008;13	CARDINAL
eyereports-54	87	2	299	CARDINAL
eyereports-54	88	1	5	CARDINAL
eyereports-54	88	2	lee a. chronic	PERSON
eyereports-54	89	1	2001;26:229-34	CARDINAL
eyereports-54	90	1	6	CARDINAL
eyereports-54	91	1	cmlsupport chronic myeloid	ORG
eyereports-54	92	1	7	CARDINAL
eyereports-54	95	1	8	CARDINAL
eyereports-54	95	2	stentoft j	PERSON
eyereports-54	95	3	ford	ORG
eyereports-54	95	4	j	PRODUCT
eyereports-54	96	1	2002	DATE
eyereports-54	96	2	359:1751	CARDINAL
eyereports-54	97	1	non -co mmerc	ORG
eyereports-54	97	2	ial	ORG